JPRN-UMIN000000688已完成未知
Efficacy and safety of two weeks rabeprazole treatment for gastric ulcers after endoscopic submucosal dissection (ESD). - Two weeks rabeprazole for ESD ulcers.
The University of Tokyo, Department of Gastroenterology0 个研究点目标入组 55 人开始时间: 2007年4月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients whose lesions were diagnosed as: depth more than sm2, resected margin positive of tumor, lesions with ulcer, tumor with diffuse type cancer. 2. Patients who required surgical intervention after ESD. 3. Patients with 2 or more lesions. 4. Patients who are allergic to PPI. 5. Patients with serious comorbid diseases. 6. Patients taking NSAIDs, steroid, anticoagulants and antiplatelets. 7. Patients who were judged inappropriate by their physicians.
研究者
相似试验
进行中（未招募）
1 期
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With RabeprazoleEUCTR2016-001879-73-Outside-EU/EEAEisai Medical Research Inc.111
尚未招募
Unknown
Clinical Efficacy of rabeprazole in patients treated with dual antiplatelet agents including potent P2Y12 inhibitors after percutaneous coronary intervention for acute coronary syndromeKCT0008344Yonsei University Yongin Severance Hospital50
招募中
Unknown
Comparative study of efficacy of rabeprazole and lansoprazole for endoscopic submucosal dissection-induced ulcerNeoplasmsKCT0008599Kangwon National University Hospital100
已完成
不适用
The efficacy and safety of rabeprazole sodium 20mg against reflux esophagitis associated with systemic sclerodermareflux esophagitis associated with systemic sclerodermaJPRN-UMIN000020701Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University40
未知
3 期
Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcersAspirin-associated ulcersJPRN-UMIN000000853niversity of Tokyo, Department of Gastroenterology100